Details for Patent: 9,963,459
✉ Email this page to a colleague
Which drugs does patent 9,963,459 protect, and when does it expire?
Patent 9,963,459 protects RINVOQ and is included in one NDA.
This patent has forty-four patent family members in thirteen countries.
Summary for Patent: 9,963,459
Title: | Processes for the preparation of (3S,4R)-3-ethyl-4-(3H-imidazo[1,2-alpla]pyrrolo[2,3-e]-pyrazin-8-YL)-N-(2- ,2,2-Trifluoroethyl)pyrrol and solid state forms thereof |
Abstract: | The present disclosure relates to processes for preparing (3S,4R)-3-ethyl-4-(3H-imidazo[1,2-a]pyrrolo[2,3-e]pyrazin-8-yl)-N-(2,2,2-- trifluoroethyl)pyrrolidine-1-carboxamide, solid state forms thereof, and corresponding pharmaceutical compositions, methods of treatment (including treatment of rheumatoid arthritis), kits, methods of synthesis, and products-by-process. |
Inventor(s): | Jayanth; Jayanthy (Buffalo, IL), Marroum; Patrick J. (Springfield, VA), Mayer; Peter T. (Libertyville, IL), Mohamed; Mohamed-Eslam F. (Gurnee, IL), Othman; Ahmed A. (Waukegan, IL) |
Assignee: | AbbVie Inc. (North Chicago, IL) |
Application Number: | 15/857,892 |
Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for patent 9,963,459 |
Patent Claim Types: see list of patent claims | Formulation; Compound; Device; Dosage form; |
Drugs Protected by US Patent 9,963,459
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Abbvie | RINVOQ | upadacitinib | TABLET, EXTENDED RELEASE;ORAL | 211675-001 | Aug 16, 2019 | RX | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | Y | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 9,963,459
Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
---|---|---|---|---|---|
Australia | 2016340167 | ⤷ Try a Trial | |||
Australia | 2020359635 | ⤷ Try a Trial | |||
Australia | 2021236570 | ⤷ Try a Trial | |||
Australia | 2023251492 | ⤷ Try a Trial | |||
>Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |